Time to take stock (take that what ever way you want)
Negitive, short term share price drop.
No early sales
Positives
Shelf life expriment showing longer life.
There-fore larger batch production, so cheaper to produce.
More profit.
Sales start to a much bigger customer base,
More profit.
Patients in Australia get acces sooner, My uncle smiles.
May help USA process (total guess).
So bottom line is we will be finacially better off at the end of 2013.